Jörg Gölz

425 total citations
18 papers, 260 citations indexed

About

Jörg Gölz is a scholar working on Epidemiology, Hepatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jörg Gölz has authored 18 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jörg Gölz's work include Hepatitis C virus research (7 papers), Opioid Use Disorder Treatment (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Jörg Gölz is often cited by papers focused on Hepatitis C virus research (7 papers), Opioid Use Disorder Treatment (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Jörg Gölz collaborates with scholars based in Germany, Estonia and Portugal. Jörg Gölz's co-authors include Markus Backmund, Norbert Scherbaum, Michael R. Kraus, Jens Siegert, Felix Tretter, Hans‐Ulrich Wïttchen, Michael Soyka, Martin Schäfer, Michael Soyka and Markus Gastpar and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and Addiction.

In The Last Decade

Jörg Gölz

18 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörg Gölz Germany 9 162 119 66 45 30 18 260
Gwenaëlle Maradan France 10 197 1.2× 85 0.7× 30 0.5× 106 2.4× 26 0.9× 51 321
Elizabeth Khuri United States 9 233 1.4× 139 1.2× 38 0.6× 27 0.6× 65 2.2× 16 342
G.H.A. van Brussel Netherlands 11 257 1.6× 198 1.7× 20 0.3× 57 1.3× 46 1.5× 15 387
Emilis Subata Lithuania 7 277 1.7× 213 1.8× 14 0.2× 99 2.2× 28 0.9× 15 362
Peter Lawrinson Australia 7 243 1.5× 150 1.3× 15 0.2× 70 1.6× 24 0.8× 7 346
Andreea Adelina Artenie Canada 13 330 2.0× 106 0.9× 203 3.1× 105 2.3× 14 0.5× 36 438
Patrick Gschwend Switzerland 7 258 1.6× 244 2.1× 25 0.4× 22 0.5× 42 1.4× 17 364
Paige Webb Australia 6 214 1.3× 86 0.7× 70 1.1× 83 1.8× 21 0.7× 13 308
Chengzheng Zhao China 7 350 2.2× 174 1.5× 23 0.3× 133 3.0× 26 0.9× 8 488
Xiaobin Cao China 12 272 1.7× 131 1.1× 21 0.3× 162 3.6× 13 0.4× 30 402

Countries citing papers authored by Jörg Gölz

Since Specialization
Citations

This map shows the geographic impact of Jörg Gölz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Gölz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Gölz more than expected).

Fields of papers citing papers by Jörg Gölz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Gölz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Gölz. The network helps show where Jörg Gölz may publish in the future.

Co-authorship network of co-authors of Jörg Gölz

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Gölz. A scholar is included among the top collaborators of Jörg Gölz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Gölz. Jörg Gölz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Murphy, Holly, Sameer Dixit, Marie Lagrange-Xélot, et al.. (2020). Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal. PLoS neglected tropical diseases. 14(12). e0008931–e0008931. 3 indexed citations
2.
Zippel‐Schultz, Bettina, Michael Specka, Thomas Eschenhagen, et al.. (2016). Outcomes of Patients in Long-Term Opioid Maintenance Treatment. Substance Use & Misuse. 51(11). 1493–1503. 17 indexed citations
3.
Reimer, Jens, Christiane Sybille Schmidt, Bernd Schulte, et al.. (2013). Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter Trial. Clinical Infectious Diseases. 57(suppl_2). S97–S104. 16 indexed citations
6.
7.
Reimer, Jens, D. Hueppe, Jörg Gölz, et al.. (2011). Longterm Benefits of Sustained Virological Response (SVR) in Patients With Chronic Hepatitis C (CHC) Virus Infection: The German Lotos Study. Gastroenterology. 140(5). S–968. 1 indexed citations
8.
Vogel, M., Golo Ahlenstiel, Thomas A. Lutz, et al.. (2010). The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals. European journal of medical research. 15(3). 102–11. 8 indexed citations
9.
Schäfer, Arne, Hans‐Ulrich Wïttchen, Markus Backmund, et al.. (2009). Psychopathological changes and quality of life in hepatitis C virus‐infected, opioid‐dependent patients during maintenance therapy. Addiction. 104(4). 630–640. 21 indexed citations
10.
Wïttchen, Hans‐Ulrich, Michael Soyka, Markus Gastpar, et al.. (2008). Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: A naturalistic study in 2694 patients. Drug and Alcohol Dependence. 95(3). 245–257. 68 indexed citations
11.
Esser, Stefan, Schlomo Staszewski, Fiona Mulcahy, et al.. (2008). 3OD – Once-daily (OD) TDF-containing HAART in HIV-1-infected former IVDU-patients receiving opiate substitution: efficacy, tolerability and adherence. Journal of the International AIDS Society. 11(Suppl 1). P76–P76. 1 indexed citations
12.
Gölz, Jörg. (2007). HIV-Prävention bei Drogenkonsumenten. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 50(4). 465–470. 1 indexed citations
13.
Hampel, Christian, Michael Schenk, Hartmut Göbel, et al.. (2006). Schmerztherapie bei suchtmittelabhängigen Patienten. Der Schmerz. 20(5). 445–459. 6 indexed citations
14.
Wïttchen, Hans‐Ulrich, Gerhard Bühringer, Markus Gastpar, et al.. (2005). Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study. International Journal of Methods in Psychiatric Research. 14(1). 14–28. 15 indexed citations
15.
Grüsser, Sabine M., et al.. (2005). A new approach to preventing relapse in opiate addicts: A psychometric evaluation. Biological Psychology. 71(3). 231–235. 18 indexed citations
16.
Salzberger, Bernd, et al.. (2004). German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004).. PubMed. 9(11). 491–504. 14 indexed citations
17.
Rockstroh, Jürgen K., Mathias Lichterfeld, Hans Dieter Nischalke, et al.. (2002). Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic hepatitis C in HIV-co-infected patients. AIDS. 16(15). 2083–2085. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026